Autologous Bone Marrow-Derived Chondrocytes for Patients with Knee Osteoarthritis: A Randomized Controlled Trial.

IF 1.2 Q3 ORTHOPEDICS
Advances in Orthopedics Pub Date : 2021-11-20 eCollection Date: 2021-01-01 DOI:10.1155/2021/2146722
Mir Sadat-Ali, Abdallah S AlOmran, Sulaiman A AlMousa, Hasan N AlSayed, Khalid W AlTabash, Mohammed Q Azam, Tarek M Hegazi, Sadananda Acharya
{"title":"Autologous Bone Marrow-Derived Chondrocytes for Patients with Knee Osteoarthritis: A Randomized Controlled Trial.","authors":"Mir Sadat-Ali,&nbsp;Abdallah S AlOmran,&nbsp;Sulaiman A AlMousa,&nbsp;Hasan N AlSayed,&nbsp;Khalid W AlTabash,&nbsp;Mohammed Q Azam,&nbsp;Tarek M Hegazi,&nbsp;Sadananda Acharya","doi":"10.1155/2021/2146722","DOIUrl":null,"url":null,"abstract":"<p><strong>Results: </strong>There were a total of 60 patients who were followed up. Three patients in Group II were removed from the analysis as they underwent total knee arthroplasty (TKA). A notably significant improvement was noticed in the ABMDC group on all scores of VAS and MKSSSF with <i>P</i> < 0.0001. The control group continued to be dissatisfied with the treatment they were taking.</p><p><strong>Conclusions: </strong>This study reveals that a single injection of 5 million of ABMDC was efficient in reducing the symptoms, improving the functional score and betterment of QOL.</p>","PeriodicalId":7358,"journal":{"name":"Advances in Orthopedics","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2021-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627347/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Orthopedics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2021/2146722","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 1

Abstract

Results: There were a total of 60 patients who were followed up. Three patients in Group II were removed from the analysis as they underwent total knee arthroplasty (TKA). A notably significant improvement was noticed in the ABMDC group on all scores of VAS and MKSSSF with P < 0.0001. The control group continued to be dissatisfied with the treatment they were taking.

Conclusions: This study reveals that a single injection of 5 million of ABMDC was efficient in reducing the symptoms, improving the functional score and betterment of QOL.

Abstract Image

Abstract Image

自体骨髓来源的软骨细胞治疗膝骨关节炎:一项随机对照试验。
结果:共随访60例患者。II组的3例患者因接受全膝关节置换术(TKA)而被从分析中剔除。ABMDC组VAS和MKSSSF评分均有显著改善(P < 0.0001)。对照组继续对他们所接受的治疗不满意。结论:单次注射500万ABMDC可有效减轻症状,改善功能评分,改善生活质量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
0.00%
发文量
36
审稿时长
21 weeks
期刊介绍: Advances in Orthopedics is a peer-reviewed, Open Access journal that provides a forum for orthopaedics working on improving the quality of orthopedic health care. The journal publishes original research articles, review articles, and clinical studies related to arthroplasty, hand surgery, limb reconstruction, pediatric orthopaedics, sports medicine, trauma, spinal deformities, and orthopaedic oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信